GlassScriptPhysician profile
Stacy D Oommen
NPI 1851500359
$575.16
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.96 · 2020: $59.33 · 2022: $202 · 2023: $204 · 2024: $30.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.05 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $85.00 | 2023 | |
| Pfizer INC. | $73.98 | 2022-2024 | |
| Abbvie INC. | $68.61 | 2020-2022 | |
| Hologic Sales and Service, LLC | $64.73 | 2019-2022 | |
| Minerva Surgical, INC | $46.70 | 2023 | |
| Boston Scientific Corporation | $36.15 | 2019-2023 | Solyx Sis System |
| Bayer Healthcare Pharmaceuticals INC. | $30.00 | 2019 | |
| Agile Therapeutics, INC. | $27.92 | 2022 | |
| Shield Therapeutics INC | $22.24 | 2022 | |
| Ethicon US, LLC | $21.64 | 2023 | Enseal |
| Sumitomo Pharma America, INC. | $20.65 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $17.99 | 2020 | |
| Organon LLC | $15.51 | 2022 | |
| Convatec INC. | $15.16 | 2023 | |
| Coopersurgical, INC. | $14.63 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $14.25 | 2024 | Vumerity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Oommen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.